K
Kiniksa Pharmaceuticals International, plc (KNSA)
NMS – Real Time Price. Currency in USD
59.48
+1.11 (1.90%)
At close: May 12, 2026, 4:00 PM EDT
59.48
0.00 (0.00%)
After-hours: May 12, 2026, 5:42 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
59.48
+1.11 (1.90%)
At close: May 12, 2026, 4:00 PM EDT
59.48
0.00 (0.00%)
After-hours: May 12, 2026, 5:42 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.79 | 2.52 | 10 | |
| Quick ratio | 3.33 | 1.78 | 10 | |
| Debt to Equity | 0.01 | -0.80 | 9.0 | |
| Debt to Assets | 0.01 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 220M | 270M | 423M | 678M | 754M |
| Gross Profit | 169M | 179M | 234M | 370M | 412M |
| Operating Income | 10M | -25M | -46M | 77M | 93M |
| Net Income | 183M | 14M | -43M | 59M | 73M |
| EBITDA | 14M | -23M | -44M | 79M | 95M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 44.49 | 31.74 | 10 |
| Next quarter | 33.45 | 54.08 | 10 |
| Current year | 38.66 | 82.63 | 10 |
| Next year | 19.9 | 37.52 | 9.5 |
| Weighted average score | 9.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.01 | 59.11 | 58.82 | -6.04 | 6.5 |
| Y/Y | 55.51 | 164.57 | 145.45 | 125.14 | 10 |
| 3y average | 46.48 | -87.45 | -89.09 | 220.25 | 5.5 |
| 5y average | 321.93 | -8.81 | -8.46 | 154.53 | 5.5 |
| Weighted average score | 6.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $190.0M significantly exceed its total debt $9.0M, ensuring strong financial flexibility
Total current assets $594.2M exceed Total current liabilities $156.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $50.0M, supporting its financial health